Literature DB >> 16990105

Hairy cell leukemia: diagnostic pathology.

Robert W Sharpe1, Kelly J Bethel.   

Abstract

The pathology of HCL has been reviewed with a focus on the diagnostic hematopathology of this rare, but fascinating, disease. The discrimination of HCL from other B-cell lymphoproliferations, particularly HCL-V and SMZL, has been emphasized. The unique responsiveness of HCL to 2-CdA and other chemotherapeutic agents makes this distinction critical. Fortunately, HCL has consistent cytologic, histologic, cytochemical, and immunologic features that make classification reliable and reproducible. Less straightforward is the differential diagnosis of SMZL and HCL-V, problematic because of the rarity of both disorders, lack of discriminating evidence-based criteria, and perhaps a biologic kinship between these two disorders that share many clinical and pathologic features. Fortunately, this is not a clinically critical distinction.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16990105     DOI: 10.1016/j.hoc.2006.06.010

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  6 in total

Review 1.  Immunoconjugates in the management of hairy cell leukemia.

Authors:  Robert J Kreitman; Ira Pastan
Journal:  Best Pract Res Clin Haematol       Date:  2015-10-09       Impact factor: 3.020

2.  Distinguishing hairy cell leukemia variant from hairy cell leukemia: development and validation of diagnostic criteria.

Authors:  Haipeng Shao; Katherine R Calvo; Marlene Grönborg; Prashant R Tembhare; Robert J Kreitman; Maryalice Stetler-Stevenson; Constance M Yuan
Journal:  Leuk Res       Date:  2013-01-22       Impact factor: 3.156

Review 3.  Hairy Cell Leukemia.

Authors:  Rossella Riccioni; Sara Galimberti; Mario Petrini
Journal:  Curr Treat Options Oncol       Date:  2007-04

Review 4.  How I treat hairy cell leukemia.

Authors:  Michael R Grever
Journal:  Blood       Date:  2009-10-20       Impact factor: 22.113

5.  Pancytopenia in a 70-year-old african-american male: an unusual presentation of a rare disease.

Authors:  Aibek E Mirrakhimov; Alaa M Ali; Aram Barbaryan; Nwabundo Anusim; Raya Saba; Shawn G Kwatra; Nasir Hussain; Teresita Zdunek; Alan D Gilman
Journal:  Case Rep Hematol       Date:  2014-02-16

Review 6.  CD5-Negative, CD10-Negative Low-Grade B-Cell Lymphoproliferative Disorders of the Spleen.

Authors:  John J Schmieg; Jeannie M Muir; Nadine S Aguilera; Aaron Auerbach
Journal:  Curr Oncol       Date:  2021-12-04       Impact factor: 3.677

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.